Fonte: Program and Abstracts. Nome do evento: International Congress of Endocrinology. Unidade: FM
Assuntos: CORTISOL (APLICAÇÕES TERAPÊUTICAS), HORMÔNIOS (DEFICIÊNCIA), TERAPIAS COMPLEMENTARES, HIPERPLASIA SUPRARRENAL CONGÊNITA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARENTE, E. et al. Final heigth in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency treated with cortisone acetate. 2004, Anais.. Lisboa: International Society of Endocrinology, 2004. . Acesso em: 04 out. 2024.APA
Parente, E., Marquezine, E., Rodrigues, a., Maureira, G., Brenlha, E. M., Ueti, R., et al. (2004). Final heigth in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency treated with cortisone acetate. In Program and Abstracts. Lisboa: International Society of Endocrinology.NLM
Parente E, Marquezine E, Rodrigues a., Maureira G, Brenlha EM, Ueti R, Arnhold I, Mendonca BB, Bachega TAS. Final heigth in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency treated with cortisone acetate. Program and Abstracts. 2004 ;[citado 2024 out. 04 ]Vancouver
Parente E, Marquezine E, Rodrigues a., Maureira G, Brenlha EM, Ueti R, Arnhold I, Mendonca BB, Bachega TAS. Final heigth in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency treated with cortisone acetate. Program and Abstracts. 2004 ;[citado 2024 out. 04 ]